Pillo Health, a Boston-based digital health company improving longevity and quality of life for patients managing their health at home has raised $11M in Series A funding, led by Stanley Black & Decker’s corporate venture capital arm with significant participation from Samsung Ventures. Existing investors, including BioAdvance, Hikma Ventures – the corporate venture capital arm of Hikma Pharmaceuticals PLC – Hackensack Meridien Health System’s Innovation Center Fund and Civilization Ventures, also participated.
What is Pillo Health?
Six in ten Americans live with at least one chronic condition, a leading driver of healthcare costs across the country. Medication non-adherence amounts up to $289 billion in wasted costs annually and leads to a higher mortality rate in the United States. Founded in 2015, Pillo Health offers partner organizations an engaging in-home interface and HIPAA-compliant technology platform and registered as an FDA Class 1 medical device to create customized voice-first health and wellness experiences; empowering them to deliver better care into the home, enhancing patient connections to their care teams, and aligning with the growing trend of voice-enabled technologies in the healthcare industry.
Pillo, a voice-activated personal home health robot with facial recognition that lets consumers better manage their health and stay connected to their caregivers. The home health assistant helps users better adhere to medication regimens, reminding them about dosages at set times, and offers them research-backed care plans to remain active and empowered in improving their health.
Redefining Medication Non-Adherence
The new Pillo home health robot provides the following core services:
Medication Management – Pillo stores and dispenses 28 doses of medication and reminds users when to take their medications to keep them on track. Pillo also reorders medications automatically before they run out.
Care Plan Delivery – Pillo delivers important instructions to users to help them stay adherent to prescribed care plans by pushing personalized health content to patients at home. Pillo can play videos on its high definition screen or recite health information via voice.
Pillo Insights – Pillo analyzes real-time health data in order to extract valuable insights from inside the home. Pillo also serves as a connection between the caregiver and the patient, by notifying the caregiver if the patient missed a dose of medication and connecting them via video.
The capital will be used to drive growth and innovation as Pillo Health builds out its voice-enabled medication and care management platform for the home. In addition, Pillo Health and Stanley Black & Decker are also jointly launching Pria by BLACK+DECKER in the U.S. later this year. Pria is powered by the Pillo Health platform and will be available for consumers to purchase in late summer online, with additional distribution channels to follow. The company is also currently hiring in its Boston, MA and Genoa, Italy offices.
“We look forward to the continued evolution of the Pillo Health platform as we work with organizations addressing the management of chronic conditions for patients at home,” said Emanuele Musini, Co-founder and CEO of Pillo Health. “Stanley Black & Decker and Samsung have made a strong commitment to the health and wellness of millions of Americans looking to remain independent longer, with a focus on tailoring voice-first technologies for their customers and revolutionizing the way healthcare is delivered into the home.”